Sun Pharmaceutical Industries (Sun Pharma) announced that it has entered into a licensing agreement with AstraZeneca UK Ltd. (AstraZeneca) to introduce certain new ready to-use (RTU) infusion oncology products in China. These products will help in cancer treatments. The agreement will play a big role in bringing cost-effective and quality drugs to patients in China.

The Government of India, acting through the Directorate General of Hydrocarbons, Ministry of Petroleum and Natural Gas, has granted its approval for a 10-year extension of the production sharing contract (PSC) to Cairn Oil & Gas vertical of Vendata Limited, for the Ravva block in Andhra Pradesh. With this extension, the PSC is now valid, effective from October 28, 2019, for the next 10 years.

Maruti Suzuki and Toyota Tsusho Group have come together to set up Maruti Suzuki Toyotsu India Private Limited (MSTI), a 'one of its kind' vehicle dismantling and recycling joint venture.

Sun Pharma Advanced Research Company Limited (SPARC) has announced the grant of exclusive licenses to a subsidiary of China Medical System Holdings Limited (CMS) to develop and commercialize multiple products in Mainland China, Hong Kong, Macao, and Taiwan.

On Tuesday, the markets ended lower, with the benchmark indices halting their 7- day’s winning streak. Although the correction was mild as the markets bounced back from lower levels soon, the weakness of the preceding session is likely to continue on Wednesday. In early action, the SGX Nifty is seen sluggish and indicating a subdued start.

The level of 11,820-11,840 is a crucial support zone. On the upside, the level of 11,980-12,000 is expected to act as a stiff resistance. Stocks in news: Infosys, Sun Pharmaceutical, Hero Motocorp, PI Industries, Quess Corp, Aditya Birla Fashion and Retail, SPARC.

This fresh capital expenditure is mainly aimed at increasing production capacities at its facilities at Roha and Mahad. This capex is likely to be funded through the blend of debt.

Breaking a five-day winning streak, Indian equity benchmarks ended the volatile day of trade marginally in red on Tuesday due to the selling in frontline blue chip stocks, despite strong trend seen in the other Asian markets.

Dabur India reported an 8% YoY rise in revenues for Q2FY20. EBIDTA grew by 27% and PAT grew by 7.2% on YoY basis. The company’s FMCG business in India reported a volume growth of 4.8%.

When it comes to investing for your financial goals or even for the wealth creation purposes, you are bound to be anxious. Many a time, this anxiety results in bad decisions that impact your investments, severely. Here, the question arises that how will you control this anxiety and protect your finances from going haywire. Read on to find out more: